Back
Open Access

Digitized validation of ECG criteria for left ventricular hypertrophy: an elite athlete CMR study

Session: Hypertrophic cardiomyopathy: diagnosis and management
Topic: Electrocardiography (ECG)
Speaker: Mr M. Van Diepen (Amsterdam, NL)
Event: ESC Preventive Cardiology 2024

Congress Presentation

Add to my library

Like

About the speaker

Mr Maarten Van Diepen

Amsterdam (Netherlands (The))
1 presentation
0 follower

10 more presentations in this session

Angiotensin II receptor blockers is associated a decreased left ventricular fibrosis in patients with obstructive hypertrophic cardiomyopathy

Speaker: Doctor C. Nie (Beijing, CN)

Access
Abstract
Slides
Like
Thumbnail

Are patients with hypertrophic cardiomyopathy given appropriate advice on exercise at a central London inherited cardiac conditions outpatient service?

Speaker: Doctor K. Sonthikaew (London, GB)

Access
Abstract
Slides
Like
Thumbnail

Cardiac magnetic resonance imaging aids in differentiating dilated cardiomyopathy from the athlete's heart

Speaker: Mr J. Daems (Utrecht, NL)

Access
Abstract
Slides
Like
Thumbnail

Optimising screening of intermediate to high-risk asymptomatic sportsmen with exercise electrocardiogram.

Speaker: Doctor D. Hupin (Saint-Etienne, FR)

Access
Abstract
Slides
Like
Thumbnail

Cardiopulmonary exercise testing in athletes and non-athletes with hypertrophic cardiomyopathy

Speaker: Doctor J. Scicluna (Msida, MT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Hypertrophic cardiomyopathy: diagnosis and management

Speakers: Mr M. Van Diepen, Doctor C. Nie, Doctor K. Sonthikaew, Mr J. Daems, Doctor D. Hupin...
Access
Like
Thumbnail

About the event

Image

ESC Preventive Cardiology 2024

25 April - 27 April 2024

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources